Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755313 · ClinicalTrials.gov registry record
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
A clinical trial of Breast Cancer and Fatigue, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 81
- Enrollment target
- 1
- Study location
NCT00755313: Completed study of Breast Cancer and Fatigue, sponsored by University of California, San Francisco.
NCT00755313 is a study of Breast Cancer and Fatigue that has completed, run by University of California, San Francisco. The registered enrollment target is 81 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00755313, a study of Breast Cancer and Fatigue, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information over time from laboratory tests, imaging scans, and assessment tests may help doctors learn more about the side effects of chemotherapy and plan the best treatment. PURPOSE: This clinical trial is studying the effects of chemotherapy on the brain in women with newly diagnosed early-stage breast cancer.
Conditions Studied
Interventions
- DRUG carboplatin
- DRUG cyclophosphamide
- DRUG docetaxel
- BIOLOGICAL trastuzumab
- DRUG aromatase inhibition therapy
Study Locations (1)
California
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2007-05 |
| Est. Completion | 2014-06-06 |
What the finished NCT00755313 record still lists
NCT00755313 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower).
The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which carboplatin is the first listed.
NCT00755313 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00755313 about?
NCT00755313 is a clinical study titled "Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer". RATIONALE: Gathering information over time from laboratory tests, imaging scans, and assessment tests may help doctors learn more about the side effects of chemotherapy and plan the best treatment. PURPOSE: This clinical trial is studying the effects of chemotherapy on the brain in women with newly...
What is the current status of trial NCT00755313?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2007-05. Estimated completion is 2014-06-06.
What conditions does trial NCT00755313 study?
This clinical trial studies the following conditions: Breast Cancer, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Neurotoxicity, Cognitive/Functional Effects.
What interventions are being tested in trial NCT00755313?
The interventions under investigation include: carboplatin (DRUG), cyclophosphamide (DRUG), docetaxel (DRUG), trastuzumab (BIOLOGICAL), aromatase inhibition therapy (DRUG).
Who is sponsoring clinical trial NCT00755313?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00755313 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00755313's enrollment target sits among peer trials
81 644th of 1224 higher than 577 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia